Patients are participating in alzheimer’s disease research around the world

We currently have a number of clinical trials and research studies seeking patients managing Alzheimer’s disease. We can help find trials and research studies near you and may help you to get access to those opportunities.

Find alzheimer’s disease clinical trials and research studies you may qualify for.

Alzheimer’s disease clinical trials and research studies

What is Alzheimer’s disease?

Alzheimer’s disease is an irreversible, progressive brain disorder that can interfere with a number of cognitive abilities such as memory, language, and behaviour. In Alzheimer’s disease, there is an accumulation of protein deposits that can either affect the connections between brain cells, preventing the normal transport of signals and energy, or cause brain cells to die. As brain cells die the brain shrinks and this can be detected with imaging technologies, which can aid in diagnosing the disease. It is these processes in the brain that cause symptoms and as different areas of the brain become affected, symptoms worsen. While the cause of Alzheimer’s disease is still unknown, there are several factors that contribute to the risk of developing the disease, such as genetics and age. The biggest risk factor is increasing age, with three in ten people over 85 having dementia.

Where is Alzheimer’s disease research now?

Alzheimer’s disease is a key focus area in biomedical research globally, particularly as there is no definitive diagnostic test and no cure. Research spans from understanding the genetic causes and potential preventative strategies, developing better tools to diagnose Alzheimer’s, drugs to help manage symptoms and discovering treatments that can stop or even reverse Alzheimer’s disease.

How can I get involved in Alzheimer’s disease research?

Participating in Alzheimer’s disease research and clinical trials may be a method to access the latest treatment drugs or it may help pave the way in developing new diagnostics and therapies that will benefit others. There are a large number of clinical trials and research studies undertaken each year to understand, prevent and treat Alzheimer’s disease.

Participants participated for alzheimer’s disease trials around the world

Opin’s direct-to-patient approach can reduce participant timelines to weeks, not months.

1,258,920
Number of Participants

required for trials.

* out of total trials participating

Alzheimer’s disease clinical trials and research studies around the world

38 trials

Phase 1

44 trials

Phase 2

21 trials

Phase 3

7 trials

Phase 4

241 trials

Others

Leading areas of alzheimer’s disease research

Types of alzheimer’s disease